梅州白带浓是怎么回事梅州整形医院排行榜,梅州人工流产手术的费用,梅州做修复双眼皮,梅州怀孕后人工流产多少钱,梅州急性宫颈炎能怀孕吗,梅州引起产后宫颈炎的原因,梅州怎么整容脸

SYDNEY, Aug. 25 (Xinhua) -- An Australian national survey has shown most respondents have been unsatisfied with their employers and managers on supporting employees with mental illness in the workplace, the charity Sane Australia said on Thursday.The survey, Australia's Working life and mental illness, by the national mental health charity Sane Australia, found that 95 percent of the 520 respondents thought employers and managers needed education on mental illness and how to manage its effects in the workplace.While more than 60 percent said their mental illness had not been a barrier when finding a job, the majority said that they haven't got any support from their employers or mangers once they were at work."The survey paints a concerning and unsatisfactory picture of Australian workplaces," SANE Australia's Executive Director Barbara Hocking said in a statement on Thursday."Many employees, including those who care for a family member with a mental illness, are being disadvantaged by a lack of flexibility, such as being able to work part-time, to work from home at times or to have adjustments made in the workplace," she said.According to the survey, two thirds of people reported to have revealed their histories of mental illness to their employer or manager.

WASHINGTON, July 18 (Xinhua) -- The U.S. National Aeronautics and Space Administration (NASA) on Monday commemorated the 90th birthday of astronaut John Glenn, the first U.S. astronaut to orbit the Earth and also the oldest person to fly to space when he launched on the space shuttle in 1998."John Glenn is a legend, and NASA sends him our best wishes on this major personal milestone," NASA Administrator Charles Bolden said in a statement. "John's legacy and contributions to the continued progress of human spaceflight are immense. His example is one we continue to emulate as we push toward farther destinations in the solar system."After a distinguished flying career with the Marines in World War II and Korea, Glenn joined NASA in 1959 as one of the country' s first astronauts in Project Mercury. On Feb. 20, 1962, Glenn piloted the Mercury-Atlas 6 "Friendship 7" spacecraft on the first U.S. manned orbital mission. He launched from NASA's Kennedy Space Center in Florida to successfully complete three orbits of the Earth.Glenn flew to space again on the STS-95 mission in 1998 aboard the space shuttle Discovery. As a mission specialist, Glenn supported deployment of a variety of research payloads and participated in investigations about spaceflight and the aging process.

BEIJING, August 4 (Xinhuanet) -- Medtronic Inc. is giving Yale University a 2.5 million U.S. dollar grant to review the safety and effectiveness of its controversial spine treatment called Infuse Bone Graft, according to The Wall Street Journals Thursday.Under terms of the pact, the company will release to Yale and eventually the public what participants described as an unprecedented amount of clinical trial and other data. The university will select two research teams from other organizations to perform separate analyses of the data.The announcement comes in the wake of a paper in June in the Spine Journal. The paper revealed that several clinical studies of Infuse, conducted by surgeons with strong economic ties to Medtronic, failed to report serious complications that arose in the trials. The critical paper also found that many of the studies were designed in ways in favor of Infuse over a treatment given to a control group.Medtronic disputes some of the findings and is conducting an internal investigation of the matter.Infuse accounts for about 700 million dollars in annual sales for Medtronic. The product is under investigation by the Senate Finance Committee over the role payments to physicians who may have played how studies were reported.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

PARIS, Aug. 19 (Xinhua) -- Marine scientists and representatives from the private sector and military establishments would meet at UNESCO at the end of this month to measure noise's impact on marine life, the Paris-based UN scientific branch UNESCO said Friday.The main agenda of the meeting, which is due from Aug. 30 to Sep. 1, was to discuss the program of the International Quiet Ocean Experiment (IQOE)."This decade-long project aims to fill the considerable knowledge gaps in this area, so that management of ocean noise can be more informed and effective," UNESCO said in a statement.The Quiet Ocean Experiments was initiated against the background that human activities on the high seas have increased significantly in recent decades, and resulted in impact upon many marine species relying mainly on sound to communicate.However, some sounds are suspected to alter the behavior of marine animals. For example, several whale species have raised the volume of the squeaks, clicks and moans by which they communicate with each other.The experiment is organized by the Scientific Committee on Oceanic Research (SCOR) and the Partnership for Observation of the Global Oceans (POGO), of which UNESCO's Intergovernmental Oceanographic Commission (IOC) is a member.